German biotech company to partner with Rwanda

- Advertisement -

BERLIN (CU)_During the past week, COVID-19 vaccinations in the Africa tripled to 13 million doses as donations of vaccines increased from developed nations. However, this still remains a drop in an ocean in a region home to 1.3 billion people, of which only 2.4 per cent has been vaccinated so far. Therefore, with the aim of setting up a sustainable Coronavirus vaccine manufacturing programme in the African continent, the government officials of Rwanda and Senegal met with the top executives of German biotechnology company BioNTech. The President of the European Commission Ursula von der Leyen also participated in the meeting that was held in Berlin on Friday (27 August).  

BioNTech is well known for its recent collaboration with…

Hot this week

A Breakthrough That Could Stop Species From Disappearing Forever

Embryo freezing is used to help reproduction in both...

India’s Next Aviation Bet May Be Coming from Moscow

The Indian aviation industry seems poised for a new...

Tragic Death of Henry Nowak: Sikh Federation Urges Unity and Fair Legal Process

The British Sikh Federation, a collective of Sikh organisations...

Canada’s Economy Stalls in Q1 ’26 as Recession Debate Intensifies Among Economists

The Canadian economy may still be struggling to grow....

A Radar, a Satellite Link, and a Mission to Save Lives: Solomon Islands’ Weather Gamble

At a regional meeting for the Weather Ready Pacific...
- Advertisement -

Related Articles

- Advertisement -sitaramatravels.comsitaramatravels.com

Popular Categories